Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects
The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...
The 2023 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Cutting-edge facilities and expertise on display at the 2023 Platform Expo
Researchers and trainees learn from the experts in an interactive half-day event
Seeking to understand how cancer spreads
A new RI-MUHC research study identifies the role of neutrophil extracellular traps in promoting cancer metastasis to the lymph nodes
Code Life Research Awards Ceremony
Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation
Two RI-MUHC trainees awarded 2023 Vanier Canada Graduate Scholarship
Congratulations to Michelle Le and Sarah Maritan!
Record turnout for Summer Student Research Day at the RI-MUHC
This annual event gives summer students a unique opportunity to present their projects to the research community
New understanding of processes involved in breast cancer metastasis
A study led by RI-MUHC researcher Nathalie Lamarche-Vane reveals the mechanisms underlying regulation...
Collaborating with industry to develop lipid nanoparticles
RI-MUHC researcher Julia Burnier heads one of two projects selected for funding by Moderna
Celebrating Pride Month with the first Pride in Research seminar
The RI-MUHC led a one-hour webinar to explore the perspectives of LGBTQIA2S+ people in the research space